BCL2 and neoplasm: It efficiently antagonizes various prosurvival members of the BCL‐2 family (BCL‐2, BCL‐xL, BCL‐w, but not MCL‐1 or A1) and increases the susceptibility of various tumor cells to apoptosis (reviewed in Ref.